Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05344898 · ClinicalTrials.gov registry record · NA

Subscap Reverse Shoulder Arthroplasty

A NA study of Rotator Cuff Injuries and Shoulder Injuries, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
118
Enrollment target
1
Study location

NCT05344898: Recruiting NA study of Rotator Cuff Injuries and Shoulder Injuries, sponsored by University of Maryland, Baltimore.

NCT05344898 is a NA study of Rotator Cuff Injuries and Shoulder Injuries that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 118 participants, above the 89-participant average among 10 other Rotator Cuff Injuries trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05344898, a NA study of Rotator Cuff Injuries and Shoulder Injuries, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
118 participants
Enrollment target
1
Study location

Study Summary

The subscapularis is part of the rotator cuff and is release as part of a reverse shoulder replacement. The decision to repair this tendon is controversial. This research is being done to help determine if rotator cuff repair improves or hinders shoulder replacement. A worrisome but rare complication after shoulder replacement is dislocation. Rotator cuff repair may help reduce this risk. The repair may hinder some of the range of motion afterwards or could help with internal rotation strength. There is a chance that the repair doesn't matter at all. The goal of this study is to delineate outcomes after reverse shoulder arthroplasty with the respect to management of the subscapularis tendon. Further information about rotator cuff repair after reverse shoulder replacement can help define complications, potentially decrease OR time, and improve functional outcomes. A total of 148 patients will be enrolled and the duration of the study will be 5 years. All patients will be required to follow-up at 2¬-week, 6-week, 3-month, 6-month, 1-year, and 2-year post-operative marks. Any time information is collected for a study there is a small risk of breach of confidentiality. There are no monetary costs or payments associated with this study. You may or may not benefit by taking part in this study. There is no guarantee that you will receive direct benefit from your participation in this study. To be clear, participation in this study is completely voluntary.

Primary Outcome

Internal rotation behind the back

Interventions

  • PROCEDURE Subscap Tenotomy
  • PROCEDURE Subscap Repair

Study Locations (1)

Maryland

  • University of Maryland School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2022-11-15
Est. Completion 2027-05-15
Phase NA
University of Maryland, Baltimore

560 total trials

What NCT05344898 shows while recruiting

NCT05344898 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, above the 89-participant average among 10 other Rotator Cuff Injuries trials with a reported enrollment target (33% higher).

The record links to 2 conditions, with Rotator Cuff Injuries appearing as the primary indexed condition, and to 2 interventions - of which Subscap Tenotomy is the first listed.

NCT05344898 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05344898 about?

NCT05344898 is a clinical study titled "Subscap Reverse Shoulder Arthroplasty". The subscapularis is part of the rotator cuff and is release as part of a reverse shoulder replacement. The decision to repair this tendon is controversial. This research is being done to help determine if rotator cuff repair improves or hinders shoulder replacement. A worrisome but rare complicatio...

What is the current status of trial NCT05344898?

This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2022-11-15. Estimated completion is 2027-05-15.

What conditions does trial NCT05344898 study?

This clinical trial studies the following conditions: Rotator Cuff Injuries, Shoulder Injuries.

What interventions are being tested in trial NCT05344898?

The interventions under investigation include: Subscap Tenotomy (PROCEDURE), Subscap Repair (PROCEDURE).

Who is sponsoring clinical trial NCT05344898?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05344898 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05344898's enrollment target sits among peer trials

118 3rd of 10 higher than 8 of 10 other Rotator Cuff Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rotator Cuff Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05344898, the US trial registry maintained by the National Library of Medicine. NCT05344898 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.